The role of long non-coding RNA HOTAIR in the progression and development of laryngeal squamous cell carcinoma interacting with EZH2

Acta Oto-Laryngologica

Volumn 137, Issue 1, 2017, Pages 90-98

  Zheng, Juan ^a   Xiao, Xiyan ^a   Wu, Chunping ^a   Huang, Jiameng ^a   Zhang, Yanping ^a   Xie, Ming ^a   Zhang, Ming ^a   Zhou, Liang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

cis platinum resistance; Clinicopathological characteristics; down regulation; inconsistence; proliferation

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CISPLATIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LONG NON CODING RNA HOTAIR; LONG UNTRANSLATED RNA; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; EZH2 PROTEIN, HUMAN; HOTAIR LONG UNTRANSLATED RNA, HUMAN;

ADULT; AGED; AMC HN8 CELL LINE; ARTICLE; CANCER PATIENT; CANCER STAGING; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HEP 2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNGEAL CANCER CELL LINE; LARYNX SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA INTERFERENCE; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING; CARCINOMA, SQUAMOUS CELL; DISEASE COURSE; DRUG RESISTANCE; GENE EXPRESSION REGULATION; LARYNGEAL NEOPLASMS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; ENHANCER OF ZESTE HOMOLOG 2 PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARYNGEAL NEOPLASMS; RNA, LONG NONCODING;

EID: 84982291317     PISSN: 00016489     EISSN: 16512251     Source Type: Journal    
DOI: 10.1080/00016489.2016.1214982     Document Type: Article

References (20)

1. Woo CJ, Kingston RE., HOTAIR lifts noncoding RNAs to new levels. Cell 2007;129:1257–59.
2. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007;129:1311–23.
3. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea MD, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 2009;106:11667–72.
4. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071–6.
5. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010;329:689–93.
6. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 2011;71:6320–26.
7. Wu SC, Kallin EM, Zhang Y., Role of H3K27 methylation in the regulation of lncRNA expression. Cell Res 2010;20:1109–16.
8. Wu L, Murat P, Matak-Vinkovic D, Murrell A, Balasubramanian S., Binding interactions between long noncoding RNA HOTAIR and PRC2 proteins. Biochemistry 2013;52:9519–27.
9. Kaneko S, Li G, Son J, Xu CF, Margueron R, Neubert TA, et al. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev 2010;24:2615–20.
10. Nakagawa T, Endo H, Yokoyama M, Abe J, Tamai K, Tanaka N, et al. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochem Biophys Res Commun 2013;436:319–24.
11. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013;32:1616–25.
12. Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren X, et al. Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma. Int J Oncol 2015;46:2586–94.
13. Wu Y, Liu J, Zheng Y, You L, Kuang D, Liu T., Suppressed expression of long non-coding RNA HOTAIR inhibits proliferation and tumourigenicity of renal carcinoma cells. Tumour Biol 2014;35:11887–94.
14. Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W, et al. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression. PLoS One 2013;8:e77293.
15. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 2011;18:1243–50.
16. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY., Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 2011;44:667–78.
17. van Kemenade FJ, Raaphorst FM, Blokzijl T, Fieret E, Hamer KM, Satijn DP, et al. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 2001;97:3896–901.
18. McDevitt MA., Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies. Semin Oncol 2012;39:109–22.
19. Benard A, Goossens-Beumer IJ, van Hoesel AQ, Horati H, Putter H, Zeestraten EC, et al. Prognostic value of polycomb proteins EZH2, BMI1 and SUZ12 and histone modification H3K27me3 in colorectal cancer. PLoS One 2014;9:e108265.
20. He SB, Zhou H, Zhou J, Zhou GQ, Han T, Wan DW, et al. Inhibition of EZH2 expression is associated with the proliferation, apoptosis and migration of SW620 colorectal cancer cells in vitro. Exp Biol Med 2015;240:458–66.